The Pharma Letter: The importance of onshoring and better control of the drug supply chain

In The Pharma Letter’s Expert View, Matthew Stober, chief executive at Abzena, discusses the challenges and opportunities shaping the future of pharmaceutical manufacturing and distribution.

The biopharmaceutical supply chain plays a pivotal role in ensuring the seamless delivery of therapeutics to patients. However, pharmaceutical supply chains face several challenges, including regulatory complexities, global competition, and the need for innovation.

Additionally, biopharma supply chains are becoming more complex with pressure to safeguard intellectual property (IP) at every stage. As a result, the biopharma industry is focusing on strategies to protect IP, including regionalization and localization, strict confidentiality agreements, and secure data-sharing protocols.

Click here to read the full article